Results 111 to 120 of about 107,795 (308)

Effect of exogenous Granulocyte Colony-Stimulating Factor on ovulation and pregnancy rate in NMRI mice

مجله دانشگاه علوم پزشکی گرگان, 2017
Background and Objective: Granulocyte colony-stimulating factors (G-CSF) and its receptor express in developing follicles, fetal and reproductive tissues. The serum G-CSF concentration significantly increases during the ovulatory phase in comparison with
F Golshan, M Shahbazi, K Haidari
doaj  

Immune Characterization of a Vietnamese Cohort With Idiopathic Inflammatory Myopathies

Muscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Idiopathic inflammatory myopathies (IIMs) are classified into five subtypes that are associated with distinct groups of myositis‐specific antibodies (MSAs). Variations in the prevalence, genetic predisposition and clinical manifestations exist in patients with IIM from different ethnic backgrounds.
Yue‐Bei Luo, Maho Nakazawa, Nham Pham Thi Minh, Léo Heinon, Inger Nennesmo, Johan Rönnelid, Ingrid E. Lundberg, Thuy Nguyen Thi Phuong, Begum Horuluoglu   +8 more
wiley   +1 more source

Human granulocyte-monocyte colony-stimulating factor and interleukin 3 stimulate monocyte cytotoxicity through a tumor necrosis factor- dependent mechanism [PDF]

, 1988
SA Cannistra, Edo Vellenga, P Groshek, A Rambaldi, JD Griffin   +4 more
openalex   +1 more source

Lymphoid Malignancies in Ataxia–Telangiectasia: Experience with Novel Targeted Therapies

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Patients with ataxia–telangiectasia (AT) face unique challenges in managing lymphoid malignancies due to heightened sensitivity to chemotherapy and radiation, requiring alternative treatment strategies. This report presents three cases demonstrating the successful integration of targeted therapies: ibrutinib for diffuse large B‐cell lymphoma ...
Samanta Catueno, Ramya Ramakrishnan, Sarah Elitzur, Miriam B. Garcia, David McCall, Cesar Nunez, Michael Roth, Alessandra Ferrajoli, Branko Cuglievan, Amber Gibson   +9 more
wiley   +1 more source

Semi‐mechanistic population PK/PD model to aid clinical understanding of myelodysplastic syndromes following treatment with Venetoclax and Azacitidine

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 448-459, March 2025.
Abstract Myelodysplastic syndromes (MDS) represent a group of bone marrow disorders involving cytopenias, hypercellular bone marrow, and dysplastic hematopoietic progenitors. MDS remains a challenge to treat due to the complex interplay between disease‐induced and treatment‐related cytopenias.
Neha Thakre, Corinna Maier, Jiuhong Zha, Benjamin Engelhardt, Johannes E. Wolff, Sven Mensing   +5 more
wiley   +1 more source

Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients.

, 1988
Gayle Cocita Baldwin, Judith C. Gasson, S G Quan, Jacob Fleischmann, Richard H. Weisbart, D Oette, Ronald T. Mitsuyasu, D. W. Golde   +7 more
openalex   +1 more source

Recombinant human TNF alpha stimulates production of granulocyte colony- stimulating factor [PDF]

, 1987
HP Koeffler, JC Gasson, J Ranyard, L Souza, Michael Shepard, Reinhold Munker   +5 more
openalex   +1 more source

Tutorial for Modeling Delays in Biological Systems in the NONMEM Software

CPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Delays in biological systems are a common phenomenon. The models for delays require specialized mathematical and numerical techniques such as transit compartments, delay differential equations (DDEs), and distributed DDEs (DDDEs). Because of mathematical complexity, DDEs and particularly DDDEs are infrequently used for modeling.
Robert J. Bauer, Wojciech Krzyzanski
wiley   +1 more source

Expression of the macrophage-specific colony-stimulating factor in human monocytes treated with granulocyte-macrophage colony-stimulating factor [PDF]

, 1987
J Horiguchi, M K Warren, Donald Küfe
openalex   +1 more source

Population Pharmacokinetics and Exposure–Response Relationships of Maribavir in Transplant Recipients With First Episode or Refractory Cytomegalovirus

CPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Maribavir's anti‐cytomegalovirus (CMV) activity and favorable safety/tolerability profile is a welcomed addition to the CMV treatment armamentarium. To further characterize pharmacokinetic (PK) and exposure–response relationships of maribavir in transplant recipients with CMV, a population PK model was updated with data from the AURORA study ...
Kefeng Sun, Claudia Jomphe, Nathalie H. Gosselin, Leon Pheng, Chandrasekar Durairaj, Yaming Hang, Indranil Bhattacharya   +6 more
wiley   +1 more source